The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Smirnova T.V.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Sheludchenko V.M.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Kozlovskaya N.L.

Department of Nephrology and Hemodialysis, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia;
Research Department of Nephrology, Research Center, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Kazarian É.É.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Andzhelova D.V.

FGBU "NII glaznykh bolezneĭ" RAMN

Sherstneva L.V.

I.M. Sechenov First Moscow State Medical University, Ophthalmology Department, 8-2 Trubetskaya St., Moscow, Russian Federation, 119991

Velieva I.A.

FGBU "NII glaznykh bolezneĭ" RAMN

Kuchieva A.M.

I.M. Sechenov First Moscow State Medical University, 8-2 Trubetskaya St., Moscow, Russian Federation, 119991

Akaeva M.I.

I.M. Sechenov First Moscow State Medical University, 8-2 Trubetskaya St., Moscow, Russian Federation, 119991

Ocular thrombotic microangiopathy in atypical hemolytic-uremic syndrome (a clinical case study)

Authors:

Smirnova T.V., Sheludchenko V.M., Kozlovskaya N.L., Kazarian É.É., Andzhelova D.V., Sherstneva L.V., Velieva I.A., Kuchieva A.M., Akaeva M.I.

More about the authors

Journal: Russian Annals of Ophthalmology. 2018;134(5): 215‑226

Read: 1047 times


To cite this article:

Smirnova TV, Sheludchenko VM, Kozlovskaya NL, et al. . Ocular thrombotic microangiopathy in atypical hemolytic-uremic syndrome (a clinical case study). Russian Annals of Ophthalmology. 2018;134(5):215‑226. (In Russ.)
https://doi.org/10.17116/oftalma2018134051215

Recommended articles:
Eculizumab in the treatment of neuromyelitis optica spectrum diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):60-65

References:

  1. Tsai HM. A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome. Transfus Med Rev. 2014;28(4):187-197. https://doi.org/10.1016/j.tmrv.2014.08.004
  2. Shen Y-M. Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome. Thromb J. 2016;14(suppl 1):19. https://doi.org/10.1186/s12959-016-0114-0
  3. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339(22):1585-1594. https://doi.org/10.1056/nejm199811263392203
  4. Phillips EH, Westwood JP, Brocklebank V, Wong EKS, Tellez JO, Marchbank KJ, McGuckin S, Gale DP, Connolly J, Goodship THJ, Kavanagh D, Scully MA. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies. J Thromb Haemost. 2016;14(1):175-185. https://doi.org/10.1111/ith.13189
  5. Spinale JM, Ruebner RL, Kaplan BS, Copelovitch L. Update on Streptococcus pneumoniae associated hemolytic uremic syndrome. Curr Opin Pediatr. 2013;25(2):203-208. https://doi.org/10.1097/mop.0b013e32835d7f2c
  6. Loirat Ch, Fremeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011;6:60. https://doi.org/10.1186/1750-1172-6-60
  7. Noris M, Remuzzi G. Atypical hemolytic uremic syndrome. N Engl J Med. 2009;361(17):1676-1687. https://doi.org/10.1056/NEJMra0902814
  8. Kozlovskaya NL, Korotchaeva YuV, Bobrova LA, Shylov EM. Atypical hemolytic-uremic syndrome in obstetric practice: the first Russian experience of diagnosis and treatment. Nefrologiya. 2016;20(2):68-80. (In Russ.) https://doi.org/10.17116/rosakush201616695-104
  9. Ramos de Carvalho JE, Schlingemann RO, Oranje M, Schlingemann RO, Oranje M, Bemelman FJ, Schooneveld MJ. Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome. Int Ophthalmol. 2018;38(1):399-407. https://doi.org/10.1007/s10792-017-0470-1
  10. Sampedro Lopez A, Dominguez Moro B, Baltar Martin JM, Garcia Monteavaro C, Barbon Garcia JJ. Ocular involvement in atypical hemolytic uremic syndrome. Arch Soc Esp Oftalmol. 2017;92(12):594-597. https://doi.org/10.1016/j.oftal.2017.02.007
  11. Greenwood GT. Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab. Int Med Case Rep J. 2015;13:235-239. https://doi.org/10.2147/imcrj.S90640
  12. David R, Hochberg-Klein S, Amer R. Resolution of ocular involvement with systemic eculizumab therapy in atypical hemolytic — uremic syndrome. Eye. 2013;27:997-998. https://doi.org/10.1038/eye.2013.111
  13. Zheng X, Gorovoy IR, Mao J, Jin J, Chen X, Cui QN. Recurrent ocular involvement in pediatric atypical hemolytic uremic syndrome. J Pediatr Ophthalmol Strabismus. 2014;51:62-65. https://doi.org/10.3928/01913913-20140923-03
  14. Larakeb A, Leroy S, Fremeaux-Bacchi V, Montchilova M, Pelosse B, Dunand O, Deschenes G, Bensman A, Ulinski T. Ocular involvement in hemolytic uremic syndrome due to factor H deficiency — are there therapeutic consequences? Pediatr Nephrol. 2007;22:1967-1970. https://doi.org/10.1007/s00467-007-0540-0
  15. Sturm V, Menke MN, Landau K, Laube GF, Neuhaus TJ. Ocular involvement in paediatric hemolytic uremic syndrome. Acta Ophthalmologica. 2010;88:804-807. https://doi.org/10.1111/j.1755-3768.2009.01552.x
  16. Dem’yanova KA, Kozlovskaya NL, Bobrova LA, Kozlov LV, Andina SS, Yurova VA, Kuchieva AM, Roshchupkina SV, Shilov EM. Complement system abnormalities in patients with atypical hemolytic uremic syndrome and catastrophic antiphospholipid syndrome. Vestnik RAMN. 2017;72(1):42-52. (In Russ.) https://doi.org/10.15690/vramn769
  17. Miguel AIM, Henriques F, Azevedo LFR, Loureiro AJR, Maberley DAL. Systematic review of Purtscher′s and Purtscher-like retinopathies. Eye. 2013;27(1):1-13. https://doi.org/10.1038/eye.2012.222
  18. Purtscher O. Noch unbekannte Befunde nach Schadeltrauma. Ber Zusammenkunft Dtsch Ophthalmol Ges. 1910;36:294.
  19. Agrawal A, McKibbin M. Purtscher′s retinopathy: epidemiology, clinical features and outcome. Br J Ophthalmol. 2007;91(11):1456-1459. https://doi.org/10.1136/bjo.2007.117408
  20. Kanski JJ, Milewski SA, Damato BE, Tanner V. Diseases of the ocular fundus. M.: MEDpress-inform; 2008. (In Russ.)
  21. Cataland SR, Holers V, Geyer S, Yang S, Wu HM. Biomarkers of the alternative pathway and terminal complement activity at presentation confirms the clinical diagnosis of aHUS and differentiates aHUS from TTP. Blood. 2014;123:3733-3738. https://doi.org/10.1182/blood-2013-12-547067

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.